Charles River Laboratories International, Inc.

Location

Massachusetts

Founded

1947-02-28

Risk Signals

1058 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Charles River Laboratories International, Inc.

Live alerts from global media, monitored by Business Radar

Charles River Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) |

2025-04-09 (nasdaq.com)

Charles River Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) |

Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on Charles River (NYSE:CRL) in the last three months. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the...

Read more
Goldman Sachs downgraded its Icon and Charles River stock ratings, and the CRO industry faces short-term challenges!

2025-03-21 (cmoney.tw)

Goldman Sachs downgraded its Icon and Charles River stock ratings, and the CRO industry faces short-term challenges!

Goldman Sachs downgraded its Icon and Charles River's stock ratings from "buy" to "neutral", pointing out that the CRO industry is facing difficulties in the near future.

Read more
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - FactSet Research Systems (NYSE:FDS), Charles River (NYSE:CRL) -

2025-03-21 (benzinga.com)

This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - FactSet Research Systems (NYSE:FDS), Charles River (NYSE:CRL) -

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Read more
Robert W. Baird Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $173.00 -

2025-02-22 (defenseworld.net)

Robert W. Baird Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $173.00 -

Read Robert W. Baird Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $173.00 at Defense World

Read more
V Square Quantitative Management LLC Purchases 121 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) -

2025-02-18 (defenseworld.net)

V Square Quantitative Management LLC Purchases 121 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) -

Read V Square Quantitative Management LLC Purchases 121 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) at Defense World

Read more
Mirae Asset Global Investments Co. Ltd. Buys 1,679 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) -

2025-02-12 (defenseworld.net)

Mirae Asset Global Investments Co. Ltd. Buys 1,679 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) -

Read Mirae Asset Global Investments Co. Ltd. Buys 1,679 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) at Defense World

Read more
Morgan Stanley Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $184.00 -

2025-02-07 (defenseworld.net)

Morgan Stanley Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $184.00 -

Read Morgan Stanley Lowers Charles River Laboratories International (NYSE:CRL) Price Target to $184.00 at Defense World

Read more
E. Ohman J or Asset Management AB Has $480,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)

2025-02-06 (marketbeat.com)

E. Ohman J or Asset Management AB Has $480,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)

E. Ohman J or Asset Management AB grew its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 225.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,600 shares of th

Read more
William Blair downgrades Charles River Labs stock to Market Performance Provided by Investing.com

2025-01-23 (investing.com)

William Blair downgrades Charles River Labs stock to Market Performance Provided by Investing.com

William Blair analysts downgraded shares of Charles River Laboratories International Inc. (NYSE: CRL) from "outperform" to "market perform" on Wednesday. The decision comes amid growing concerns about the company's near-term prospects, with the stock currently trading near its 52-week low of $160.84.

Read more

Never miss a headline about Charles River Laboratories International, Inc.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages